Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
08/11/2025
Taliban spokesperson: Pakistan is not prepared to take on the responsibility of maintaining its own domestic security, so the negotiations have not yielded any results.
Latest
7 m ago
When conducting research in Guizhou, Chen Wenqing stated that we must thoroughly study and implement the spirit of the Fourth Plenary Session of the 20th CPC Central Committee, and work hard to build a higher level of law-based China with stability.
13 m ago
After competing with Norvatis and Novartis for the acquisition of a startup company focused on weight loss medications, Pfizer has finalized the acquisition of Metsera for $10 billion. Norvatis and Novartis have stated that after careful evaluation, they have decided not to increase their acquisition offer and will continue to focus on business expansion and other acquisition opportunities. According to the agreement, Pfizer will complete the transaction at a price of up to $86.25 per share, including an initial cash payment of $65.60 per share and an additional consideration of up to $20.65 per share if certain performance targets are met.
18 m ago
Pfizer plans to acquire Metsera for $10 billion, and Novo Nordisk withdraws from the bidding war.
24 m ago
UNFPA Representative in China: The silver hair market in China has huge potential.
34 m ago
President of the China General Chamber of Commerce in the United States, Tan Sen: American companies look forward to becoming century-old shops in China.
See all latest